The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes-Reference-Cited by-同舟云学术

The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes

Published:2023-08 Issue: Volume:65 Page:152137
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Atılgan Alev Ok^ORCID,Tepeoğlu Merih^ORCID,Özen Özlem^ORCID,Reyhan A. Nihan Haberal^ORCID,Ayhan Ali^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference27 articles.

1. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?;McCluggage;J Clin Pathol,2002

2. The PD1:PD-L1/2 pathway from discovery to clinical implementation;Bardhan;Front Immunol,2016

3. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics;Imai;Carcinogenesis,2008

4. Landscape of microsatellite instability across 39 cancer types;Bonneville;JCO Precis Oncol,2017

5. Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer;Yamashita;Oncotarget,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of PD-L1 expression and tumor-infiltrating lymphocytes in metaplastic breast carcinoma and gynecologic carcinosarcoma: A single-institution retrospective study;Annals of Diagnostic Pathology;2024-12

2. Regulatory T cells as crucial trigger and potential target for hyperprogressive disease subsequent to PD-1/PD-L1 blockade for cancer treatment;International Immunopharmacology;2024-05

3. Role of Immunotherapy in Sarcomas;International Journal of Molecular Sciences;2024-01-19